Make screening a programme, not a one-off.
FIT-based colorectal screening and quantitative GI assays — plus the pathway support that turns one enrolled patient into a recurring screening relationship.
The opportunity
Colorectal-cancer screening is recurring by design — an average-risk adult re-tests on a fixed cycle, and FIT-based programmes are typically run annually or biennially depending on the pathway the programme follows. One enrolled patient is not one test; it's a test every cycle for years, plus the referrals a positive generates. Guaiac FOBT carries diet restrictions and peroxidase interference; FIT is specific to human haemoglobin and needs no diet prep.
What we bring
- ColonView — FIT built for screening throughput
- QuantOn Cal — quantitative faecal calprotectin to triage inflammation
- Pancreatic Elastase ELISA — the lab reference method
- Programme support — recall pathway and referring-clinician loop
Model the screening annuity
A recall-based FIT programme compounds volume; occasional occult-blood tests don't. Size it for your throughput.
Talk to us about the economics →Products for laboratories
Biotical H.pylori Stool Ag
A stool antigen test for H. pylori — a non-invasive option where endoscopy is not indicated.
View evidence → BiohitColonView
A FIT-based faecal occult blood test built for colorectal-cancer screening programmes.
View evidence → Immundiagnostik AG (IDK)QuantOn Cal
A point-of-care test that measures faecal calprotectin quantitatively — read on a smartphone.
View evidence → ScheBo (F.E.1)Pancreatic Elastase Quick
A rapid point-of-care test for pancreatic elastase-1 — a marker of exocrine pancreatic function.
View evidence → ScheBo (F.E.1 ELISA)Pancreatic Elastase ELISA
A quantitative ELISA for pancreatic elastase-1 — the laboratory reference method.
View evidence →Build your screening programme
We'll help size the assay, the recall loop and the economics.